Screening for Cognitive Dysfunctions in Patients with Combined Hashish and Tramadol Addiction

Screening for Cognitive Dysfunctions in Patients with Combined Hashish and Tramadol Addiction

Surayyo Z. Yuldasheva

Contact

Inara Khayretdinova

Contact

Zarifjon Ashurov

Contact

Nargiza Yadgarova

Contact

Screening for Cognitive Dysfunctions in Patients with Combined Hashish and Tramadol Addiction

Article Fingerprint

ReserarchID

7JO5H

Screening for Cognitive Dysfunctions in Patients with Combined Hashish and Tramadol Addiction Banner

AI TAKEAWAY

Connecting with the Eternal Ground

References

34 Cites in Article

Reference Format

(2020). UNODC/WHO International Standards for the Treatment of Drug Use Disorders.
H Curran,Tom Freeman,Claire Mokrysz,David Lewis,Celia Morgan,Loren Parsons (2016). Keep off the grass? Cannabis, cognition and addiction.
M Field,W Cox (2008). Attentional bias in addictive behaviors: A review of its development, causes, and consequences.
C Perry,A Lawrence (2017). Addiction, cognitive decline and therapy: seeking ways to escape a vicious cycle.
Nora Volkow,James Swanson,A Evins,Lynn Delisi,Madeline Meier,Raul Gonzalez,Michael Bloomfield,H Curran,Ruben Baler (2016). Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review.
Egon Hagen,Aleksander Erga,Katrin Hagen,Sverre Nesvåg,James Mckay,Astri Lundervold,Espen Walderhaug (2016). Assessment of Executive Function in Patients With Substance Use Disorder: A Comparison of Inventory- and Performance-Based Assessment.
T Gould (2010). Addiction and cognition.
Claudia Juárez,Tania Molina-Jiménez,Jean-Pascal & Morin,Roldán-Roldán,& Gabriel,Rossana Zepeda (2018). Influence of Drugs on Cognitive Functions.
T Agibalova,K Poplevchenkov (2012). Clinical symptoms and personality traits in patients using psychostimulant drugs and other psychoactive substances.
Marc Copersino (2017). Cognitive mechanisms and therapeutic targets of addiction.
R Wiers,A Stacy (2006). Implicit Cognition and Addiction.
V Yaltonsky,N Sirota,A Yaltonskaya (2017). The combined use of drugs and other psychoactive substances by adolescents as an urgent problem of narcology. // Issues of narcology.
Medhat Bassiony,Usama Youssef,Mervat Hassan,Ghada Salah El-Deen,Hayam El-Gohari,Mohamed Abdelghani,Ahmed Abdalla,Dalia Ibrahim (2017). Cognitive Impairment and Tramadol Dependence.
Y Miao,J Tian,J Shi,M Mao (2012). Effects of Chinese medicine for tonifying the kidney and resolving phlegm and blood stasis in treating patients with amnestic mild cognitive impairment: A randomized, double-blind and parallel-controlled trial.
Amir Levine,Kelly Clemenza,Moira Rynn,Jeffrey Lieberman (2017). Evidence for the Risks and Consequences of Adolescent Cannabis Exposure.
Dan Lubman,Ali Cheetham,Murat Yücel (2015). Cannabis and adolescent brain development.
A Shrivastava,M Johnston,M Tsuang (2011). Cannabis use and cognitive dysfunction.
L Tursunkhojaeva,T Rustamova Zh (2007). Comparative assessment of memory functions in patients with opium-hashish poly drug addiction and opium mono-drug addiction // Neurology.
Marc Copersino,David Schretlen,Garrett Fitzmaurice,Scott Lukas,Judith Faberman,Jody Sokoloff,Roger Weiss (2012). Effects of Cognitive Impairment on Substance Abuse Treatment Attendance: Predictive Validation of a Brief Cognitive Screening Measure.
Mehmet Sofuoglu (2010). Cognitive enhancement as a pharmacotherapy target for stimulant addiction.
Marc Copersino,William Fals-Stewart,Garrett Fitzmaurice,David Schretlen,Jody Sokoloff,Roger Weiss (2009). Rapid cognitive screening of patients with substance use disorders..
Linwei Wang,Jeong Min,Emanuel Krebs,Elizabeth Evans,David Huang,Lei Liu,Yih-Ing Hser,Bohdan Nosyk (2017). Polydrug use and its association with drug treatment outcomes among primary heroin, methamphetamine, and cocaine users.
A Polunina,D Davydov,E Brun (2004). Neuropsychological studies of cognitive impairments in alcoholism and drug addiction // Psychological journal.
Sultanov Sh,Kh,N Khodzhaeva,A Kharyakova (2019). Correction of cognitive impairments in heroin addiction with the nootropic drug alcheba (memantine) // Anthology of Russian psychotherapy and psychology.
J Allan,S Collings,A Munro (2019). The process of change for people with cognitive impairment in a residential rehabilitation program for substance problems: a phenomenographical analysis.
K Carroll,B Kiluk,C Nich,T Babuscio,J Brewer,M Potenza,S Ball,S Martino,B Rounsaville,C Lejuez (2011). Cognitive function and treatment response in a randomized clinical trial of computer-based training in cognitivebehavioral therapy.
Sara Domínguez-Salas,Carmen Díaz-Batanero,Oscar Lozano-Rojas,Antonio Verdejo-García (2016). Impact of general cognition and executive function deficits on addiction treatment outcomes: Systematic review and discussion of neurocognitive pathways.
Antonio Yam,Trevor Chong,Julie Stout,Yucel,Edythe Murat & London (2017). Stages of dysfunctional decision-making in addiction.
K Willock,Н Сапронов (2010). Screening Drug and Alcohol participants for mild cognitive impairment: why, how and does it matter? 30.
Ziad Nasreddine,Natalie Phillips,Valérie Bédirian,Simon Charbonneau,Victor Whitehead,Isabelle Collin,Jeffrey Cummings,Howard Chertkow (2005). The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment.
Parunyou Julayanont,Natalie Phillips,Howard Chertkow,Ziad Nasreddine (2013). Montreal Cognitive Assessment (MoCA): Concept and Clinical Review.
А Ivkin,E Grigoriev,D Shukevich (2018). DIAGNOSTICS OF COGNITIVE DYSFUNCTION IN PATIENTS IN THE INTENSIVE CARE WARDS.
John Hobson (2015). The Montreal Cognitive Assessment (MoCA).
Alessandra Thomann,Nicolai Goettel,Raphael Monsch,Manfred Berres,Thomas Jahn,Luzius Steiner,Andreas Monsch (2018). The Montreal Cognitive Assessment: Normative Data from a German-Speaking Cohort and Comparison with International Normative Samples.

Download References

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Surayyo Z. Yuldasheva. 2020. \u201cScreening for Cognitive Dysfunctions in Patients with Combined Hashish and Tramadol Addiction\u201d. Global Journal of Medical Research - A: Neurology & Nervous System GJMR-A Volume 20 (GJMR Volume 20 Issue A3): .

More Citation Formats

Select Citation Style:

Download Citation

Download Article

GJMR Volume 20 Issue A3
Pg. 1- 7

Explore Journals Explore Volume Read This Issue

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords

Not Found

Classification

GJMR-A Classification: NLMC Code: WS 462

Submission ReceivedDecember 12, 2019
Peer Review Double Blind
Handling Editor
Accepted December 31, 2019
Published January 15, 2020

Version of record

v1.2

Issue date

October 24, 2020

Language

Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

View in VR

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

View in 3D

Article Matrices

Total Views: 2130

Total Downloads: 1002

2026 Trends

Published Article

Abstract not found

Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]